We are live on ! Find out more
BM

Brandywine Managers Portfolio holdings

AUM $170M
1-Year Est. Return 10.01%
This Fund
S&P 500
This Quarter Est. Return
-1.62%
1 Year Est. Return
+10.01%
3 Year Est. Return
+53.1%
5 Year Est. Return
+7.42%
10 Year Est. Return
+248.69%
AUM
$59.3M
AUM Growth
-$92.2M
Cap. Flow
-$90.6M
Cap. Flow %
-152.84%
Top 10 Hldgs %
76.36%
Holding
49
New
1
Increased
2
Reduced
1
Closed
11

Sector Composition

1 Technology 46.81%
2 Healthcare 13.72%
3 Consumer Staples 1.66%
4 Financials 1.19%
5 Consumer Discretionary 0.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GH icon
26
Guardant Health
GH
$20.7B
$472K 0.8%
15,933
TXG icon
27
10x Genomics
TXG
$5.55B
$462K 0.78%
11,208
TWST icon
28
Twist Bioscience
TWST
$5.84B
$425K 0.72%
20,970
SNOW icon
29
Snowflake
SNOW
$93.2B
$389K 0.66%
2,549
PRME icon
30
Prime Medicine
PRME
$565M
$315K 0.53%
32,977
SMAR
31
DELISTED
Smartsheet Inc.
SMAR
$312K 0.53%
7,700
RLAY icon
32
Relay Therapeutics
RLAY
$4.34B
$267K 0.45%
31,807
ABCL icon
33
AbCellera Biologics
ABCL
$1.97B
$262K 0.44%
56,976
U icon
34
Unity
U
$12.7B
$261K 0.44%
8,327
RBLX icon
35
Roblox
RBLX
$37B
$210K 0.35%
7,241
OLK
36
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$201K 0.34%
13,600
FULC icon
37
Fulcrum Therapeutics
FULC
$243M
$116K 0.2%
26,127
CELL
38
DELISTED
PhenomeX Inc. Common Stock
CELL
$29.7K 0.05%
29,772
ADP icon
39
Automatic Data Processing
ADP
$102B
-53,287
Closed -$11.7M
BEAM icon
40
Beam Therapeutics
BEAM
$2.83B
-8,067
Closed -$258K
CLX icon
41
Clorox
CLX
$11.6B
-35,725
Closed -$5.68M
DNLI icon
42
Denali Therapeutics
DNLI
$3.7B
-9,601
Closed -$283K
DOCU
43
DocuSign
DOCU
$10.1B
-4,211
Closed -$215K
EXPD icon
44
Expeditors International
EXPD
$23.9B
-35,295
Closed -$4.28M
KDP icon
45
Keurig Dr Pepper
KDP
$42.1B
-292,640
Closed -$9.15M
PG icon
46
Procter & Gamble
PG
$349B
-157,395
Closed -$23.9M
PM icon
47
Philip Morris
PM
$301B
-207,202
Closed -$20.2M
SBUX icon
48
Starbucks
SBUX
$120B
-107,772
Closed -$10.7M
ZBRA icon
49
Zebra Technologies
ZBRA
$12.7B
-22,871
Closed -$6.77M

Similar funds

Brandywine Managers's Q3 2023 Portfolio in Review

As of Q3 2023, Brandywine Managers held 49 positions worth $59.3M, down 61% from $151M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Brandywine Managers withdrew a net $90.6M in Q3 2023, closing 11 positions and reducing 1 holding. Its most notable exit was Procter & Gamble, an estimated $23.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Brandywine Managers opened a new position in Structure Therapeutics worth $555K.

  • Brandywine Managers's largest Q3 2023 buy was Structure Therapeutics: 11,000 shares worth $555K.
  • Brandywine Managers added most to iShares MSCI ACWI ETF in Q3 2023, an estimated $1.65M increase.
  • Brandywine Managers's biggest Q3 2023 reduction was Natera, cutting an estimated $153K.
  • Brandywine Managers fully exited Procter & Gamble in Q3 2023, selling an estimated $23.9M.
  • Brandywine Managers's ten largest holdings make up 76% of its $59.3M portfolio in Q3 2023.
  • Brandywine Managers opened 1 new position and closed 11 in Q3 2023.
  • Brandywine Managers's portfolio value fell 61% quarter-over-quarter to $59.3M.

Based on Brandywine Managers's 13F filing for Q3 2023, filed 14 Nov 2023.